GATA4 loss-of-function mutation underlies familial dilated cardiomyopathy

Biochemical and Biophysical Research Communications

Volumn 439, Issue 4, 2013, Pages 591-596

  Li, Ruo Gu ^a   Li, Li ^b   Qiu, Xing Biao ^a   Yuan, Fang ^a   Xu, Lei ^a   Li, Xin ^a   Xu, Ying Jia ^a   Jiang, Wei Feng ^a   Jiang, Jin Qi ^a   Liu, Xu ^a   Fang, Wei Yi ^a   Zhang, Min ^a   Peng, Lu Ying ^b   Qu, Xin Kai ^a   Yang, Yi Qing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Dilated cardiomyopathy; GATA4; Genetics; NKX2 5; Transcription factor

Indexed keywords

AMINO ACID; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5;

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; IDIOPATHIC DISEASE; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

DILATED CARDIOMYOPATHY; GATA4; GENETICS; NKX2-5; TRANSCRIPTION FACTOR;

ADULT; CARDIOMYOPATHY, DILATED; FEMALE; GATA4 TRANSCRIPTION FACTOR; GENETIC PREDISPOSITION TO DISEASE; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; MUTATION; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 84884702111     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.09.023     Document Type: Article

References (32)

1. Lakdawala N.K., Winterfield J.R., Funke B.H. Dilated cardiomyopathy. Circ. Arrhythm. Electrophysiol. 2013, 6:228-237.
2. McNally E.M., Golbus J.R., Puckelwartz M.J. Genetic mutations and mechanisms in dilated cardiomyopathy. J. Clin. Invest. 2013, 123:19-26.
3. Pikkarainen S., Tokola H., Kerkelä R., Ruskoaho H. GATA transcription factors in the developing and adult heart. Cardiovasc. Res. 2004, 63:196-207.
4. Perrino C., Rockman H.A. GATA4 and the two sides of gene expression reprogramming. Circ. Res. 2006, 98:715-716.
5. Brody M.J., Cho E., Mysliwiec M.R., Kim T.G., Carlson C.D., Lee K.H., Lee Y. Lrrc10 is a novel cardiac-specific target gene of Nk2-5 and GATA4. J. Mol. Cell Cardiol. 2013, 62:237-246.
6. Garg V., Kathiriya I.S., Barnes R., Schluterman M.K., King I.N., Butler C.A., Rothrock C.R., Eapen R.S., Hirayama-Yamada K., Joo K., Matsuoka R., Cohen J.C., Srivastava D. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 2003, 424:443-447.
7. Nemer G., Fadlalah F., Usta J., Nemer M., Dbaibo G., Obeid M., Bitar F. A novel mutation in the GATA4 gene in patients with Tetralogy of Fallot. Hum. Mutat. 2006, 27:293-294.
8. Rajagopal S.K., Ma Q., Obler D., Shen J., Manichaikul A., Tomita-Mitchell A., Boardman K., Briggs C., Garg V., Srivastava D., Goldmuntz E., Broman K.W., Benson D.W., Smoot L.B., Pu W.T. Spectrum of heart disease associated with murine and human GATA4 mutation. J. Mol. Cell Cardiol. 2007, 43:677-685.
9. McCulley D.J., Black B.L. Transcription factor pathways and congenital heart disease. Curr. Top Dev. Biol. 2012, 100:253-277.
10. Molkentin J.D., Lin Q., Duncan S.A., Olson E.N. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev. 1997, 11:1061-1072.
11. Kuo C.T., Morrisey E.E., Anandappa R., Sigrist K., Lu M.M., Parmacek M.S., Soudais C., Leiden J.M. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev. 1997, 11:1048-1060.
12. Pu W.T., Ishiwata T., Juraszek A.L., Ma Q., Izumo S. GATA4 is a dosage-sensitive regulator of cardiac morphogenesis. Dev. Biol. 2004, 275:235-244.
13. Oka T., Maillet M., Watt A.J., Schwartz R.J., Aronow B.J., Duncan S.A., Molkentin J.D. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ. Res. 2006, 98:837-845.
14. Suzuki Y.J., Evans T. Regulation of cardiac myocyte apoptosis by the GATA-4 transcription factor. Life Sci. 2004, 74:1829-1838.
15. Kikuchi K., Holdway J.E., Werdich A.A., Anderson R.M., Fang Y., Egnaczyk G.F., Evans T., Macrae C.A., Stainier D.Y., Poss K.D. Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes. Nature 2010, 464:601-605.
16. Qian L., Huang Y., Spencer C.I., Foley A., Vedantham V., Liu L., Conway S.J., Fu J.D., Srivastava D. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012, 485:593-598.
17. Song K., Nam Y.J., Luo X., Qi X., Tan W., Huang G.N., Acharya A., Smith C.L., Tallquist M.D., Neilson E.G., Hill J.A., Bassel-Duby R., Olson E.N. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012, 485:599-604.
18. Lyons I., Parsons L.M., Hartley L., Li R., Andrews J.E., Robb L., Harvey R.P. Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nk2-5. Genes Dev. 1995, 9:1654-1666.
19. Prall O.W., Menon M.K., Solloway M.J., Watanabe Y., Zaffran S., Bajolle F., Biben C., McBride J.J., Robertson B.R., Chaulet H., Stennard F.A., Wise N., Schaft D., Wolstein O., Furtado M.B., Shiratori H., Chien K.R., Hamada H., Black B.L., Saga Y., Robertson E.J., Buckingham M.E., Harvey R.P. An Nk2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell 2007, 128:947-959.
20. Pashmforoush M., Lu J.T., Chen H., Amand T.S., Kondo R., Pradervand S., Evans S.M., Clark B., Feramisco J.R., Giles W., Ho S.Y., Benson D.W., Silberbach M., Shou W., Chien K.R. Nk2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell 2004, 117:373-386.
21. Schott J.J., Benson D.W., Basson C.T., Pease W., Silberbach G.M., Moak J.P., Maron B.J., Seidman C.E., Seidman J.G. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998, 281:108-111.
22. Reamon-Buettner S.M., Borlak J. NKX2-5: an update on this hypermutable homeodomain protein and its role in human congenital heart disease (CHD). Hum. Mutat. 2010, 31:1185-1194.
23. Costa M.W., Guo G., Wolstein O., Vale M., Castro M.L., Wang L., Otway R., Riek P., Cochrane N., Furtado M., Semsarian C., Weintraub R.G., Yeoh T., Hayward C., Keogh A., Macdonald P., Feneley M., Graham R.M., Seidman J.G., Seidman C.E., Rosenthal N., Fatkin D., Harvey R.P. Functional characterization of a novel mutation in NKX2-5 associated with congenital heart disease and adult-onset cardiomyopathy. Circ. Cardiovasc. Genet. 2013, 6:238-247.
24. Elliott P., O'Mahony C., Syrris P., Evans A., Rivera Sorensen C., Sheppard M.N., Carr-White G., Pantazis A., McKenna W.J. Prevalence of desmosomal protein gene mutations in patients with dilated cardiomyopathy. Circ. Cardiovasc. Genet. 2010, 3:314-322.
25. Liu X.Y., Wang J., Zheng J.H., Bai K., Liu Z.M., Wang X.Z., Liu X., Fang W.Y., Yang Y.Q. Involvement of a novel GATA4 mutation in atrial septal defects. Int. J. Mol. Med. 2011, 28:17-23.
26. Zhu W., Shiojima I., Hiroi Y., Zou Y., Akazawa H., Mizukami M., Toko H., Yazaki Y., Nagai R., Komuro I. Functional analyses of three Csx/Nkx-2.5 mutations that cause human congenital heart disease. J. Biol. Chem. 2000, 275:35291-35296.
27. Schlesinger J., Schueler M., Grunert M., Fischer J.J., Zhang Q., Krueger T., Lange M., Tönjes M., Dunkel I., Sperling S.R. The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs. PLoS Genet. 2011, 7. e1001313.
28. Liang Q., De Windt L.J., Witt S.A., Kimball T.R., Markham B.E., Molkentin J.D. The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J. Biol. Chem. 2001, 276:30245-30253.
29. Kirk E.P., Sunde M., Costa M.W., Rankin S.A., Wolstein O., Castro M.L., Butler T.L., Hyun C., Guo G., Otway R., Mackay J.P., Waddell L.B., Cole A.D., Hayward C., Keogh A., Macdonald P., Griffiths L., Fatkin D., Sholler G.F., Zorn A.M., Feneley M.P., Winlaw D.S., Harvey R.P. Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am. J. Hum. Genet. 2007, 81:280-291.
30. Yang Y.Q., Wang M.Y., Zhang X.L., Tan H.W., Shi H.F., Jiang W.F., Wang X.H., Fang W.Y., Liu X. GATA4 loss-of-function mutations in familial atrial fibrillation. Clin. Chim. Acta 2011, 412:1825-1830.
31. Jiang J.Q., Shen F.F., Fang W.Y., Liu X., Yang Y.Q. Novel GATA4 mutations in lone atrial fibrillation. Int. J. Mol. Med. 2011, 1025-1032.
32. Wang J., Sun Y.M., Yang Y.Q. Mutation spectrum of the GATA4 gene in patients with idiopathic atrial fibrillation. Mol. Biol. Rep. 2012, 39:8127-8135.